Maksun Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.13 Cr
as on 15-12-2024
- Revenue 34.95%
(FY 2023)
- Profit 44.54%
(FY 2023)
- Ebitda 60.91%
(FY 2023)
- Net Worth 13.35%
(FY 2023)
- Total Assets 43.45%
(FY 2023)
About Maksun Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹12.13 Cr.
Ruchir Kumar, Darshan Arora, and Himanshu serve as directors at the Company.
- CIN/LLPIN
U24233HR2013PTC050458
- Company No.
050458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maksun Biotech Private Limited offer?
Maksun Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes.
Who are the key members and board of directors at Maksun Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshan Arora  | Director | 04-Nov-2013 | Current |
| Ruchir Kumar | Director | 19-Sep-2013 | Current |
| Himanshu | Director | 19-Sep-2013 | Current |
Financial Performance of Maksun Biotech.
Maksun Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.95% increase. The company also saw a substantial improvement in profitability, with a 44.54% increase in profit. The company's net worth Soared by an impressive increase of 13.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maksun Biotech?
Unlock access to Maksun Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Mar 2023 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Jul 2022 | ₹6.15 Cr | Open |
Others Creation Date: 28 Jun 2022 | ₹1.08 Cr | Open |
How Many Employees Work at Maksun Biotech?
Unlock and access historical data on people associated with Maksun Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maksun Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maksun Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
